The emerging role of epigenetics in cardiovascular disease

Area of Science:

• Cardiovascular Medicine
• Epigenetics
• Molecular Biology

Background:

• Cardiovascular diseases represent a global epidemic with significant public health and economic impact.
• Foundational research in epidemiology, pathophysiology, and genetics has advanced cardiovascular diagnosis and treatment.
• Epigenetics, defined as heritable changes in gene expression not due to DNA sequence alterations, is increasingly recognized for its role.

Purpose of the Study:

• To review the emerging role of epigenetics in cardiovascular medicine.
• To highlight epigenetic mechanisms in major cardiovascular conditions.
• To explore potential epigenetic therapeutics for cardiovascular diseases.

Main Methods:

• Literature review of studies on epigenetics and cardiovascular disease.
• Analysis of epigenetic involvement in pathophysiology and therapeutics.
• Focus on specific cardiovascular specialties including coronary artery disease, heart failure, cardiac hypertrophy, and diabetes.

Main Results:

• Epigenetics acts as a key regulator at various levels of cardiovascular disease, from pathophysiology to treatment.
• Emerging evidence links epigenetic modifications to major cardiovascular conditions.
• The review synthesizes current understanding of epigenetics in coronary artery disease, heart failure, cardiac hypertrophy, and diabetes.

Conclusions:

• Epigenetics is a critical factor in the development and progression of cardiovascular diseases.
• Further research into epigenetic mechanisms can unlock novel diagnostic and therapeutic targets.
• Targeting epigenetic pathways holds promise for innovative cardiovascular medicine strategies.